Vase, M. Ø., Hellberg, Y., larsen, C. S., Petersen, E., Schaumburg, H., Bendix, K., Ravel, C., Bastien, P., Christensen, M.
& D'Amore, F. A. (2012).
Development of a splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica,
128(1), 20-22.
Clausen, M. R.
, Ulrichsen, S. P., Larsen, T. S., Poulsen, C. B., Tojaga, S., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M.
& d'Amore, F. (2019).
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.
Leukemia and Lymphoma,
60(8), 1950-1957.
https://doi.org/10.1080/10428194.2018.1554863
Rosenberg, C. A., Toft-Petersen, M., Linck, H., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2017).
Delineating distinct stages of early erythropoiesis in human bone marrow employing imaging flow cytometry. Abstract from Nordic Flow Cytometry Meeting, Copenhagen, Denmark.
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A. M. D., Karkkainen, M. J., Tainola, T.
, Pedersen, F. S., Sørensen, A. B., Kühle, A. V. D. A. & d'Amore, F. A. (2008).
Correlation between epstein-barr virus (EBV) RNA expression and vascular endothelial growth factor (VEGF) expression in different subtypes of peripheral T-cell lymphomas (PTCL) and prognostic implications. In
ANNALS OF ONCOLOGY (Vol. 19, pp. 113-113)
D'Amore, F. A., Jurczak, W., Skotnicki, A. B., Deptala, A., Windemuth-Kieselbach, C., Lorsbach, M., Delaloye, A. B., Cheolwon, S., Zinzani, P. L., Cacchione, R., Linkesch, W. & Truemper, L. H. (2009).
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the international RIT-network.
Blood,
114(22), 22.
Zinzani, P. L.
, d'Amore, F., Bombardieri, E., Brammer, C., Codina, J. G., Illidge, T., Jurczak, W., Linkesch, W., Morschhauser, F., Vandenberghe, E. & Van Hoof, A. (2008).
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European Journal of Cancer,
44(3), 366-73.
https://doi.org/10.1016/j.ejca.2007.12.008
Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J.
, Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M. ... Chan, W. C. (2016).
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
Leukemia,
31(1), 83-91.
https://doi.org/10.1038/leu.2016.175
Holst, J. M., Enemark, M. B., Plesner, T. L.
, Pedersen, M. B., Ludvigsen, M. & d'Amore, F. (2021).
Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Case Reports in Hematology,
2021, Article 6623706.
https://doi.org/10.1155/2021/6623706
Pedersen, M. B., Zhao, Y., Arendrup, MC., Bendix, K., Bojsen-Møller, M., Mølle, I.
& D'Amore, F. A. (2011).
Co-existence of cerebral infection with Rhinocladiella mackenzei and primary central nervous system lymphoma in a HIV-negative patient.
Acta Pathologica et Microbiologica Scandinavica APMIS,
119(3), 221-223.
Soerensen, J. F., Aggerholm, A., Kerndrup, G. B.
, Hansen, M. C., Ewald, I. K. L.
, Bill, M., Ebbesen, L. H.
, Rosenberg, C. A., Hokland, P., Ludvigsen, M. & Stidsholt Roug, A. (2020).
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Blood Advances,
4(5), 885-892.
https://doi.org/10.1182/bloodadvances.2019001157
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B., Ebbesen, L. H.
, Hansen, M. H., Roug, A. S. & Ludvigsen, M. (2022).
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Bone Marrow Transplantation,
57(3), 460-465.
https://doi.org/10.1038/s41409-022-01567-z
Petruskevicius, I.
, Ludvigsen, M., Hjortebjerg, R.
, Sørensen, B. S., Kamper, P., Vase, M. Ø.
, Oestgaard, L. G., Nielsen, B.
, Honoré, B., Bjerre, M., Rabinovich, G. A.
& d'Amore, F. A. (2016).
Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation.
Bone Marrow Transplantation,
51(10), 1387-1390.
https://doi.org/10.1038/bmt.2016.127
Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C.
, d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E. ... Savani, B. N. (2017).
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation,
23(11), 1826-1838.
https://doi.org/10.1016/j.bbmt.2017.07.027
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Segel, E., Bendix, K., Jensen, B. A., Jensen, P., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2014).
Clinical outcome determinats for sequentially transformed indolent lymphomas treated with or without autologous stem cell transplantation.
Blood,
124(21).
El-Galaly, T. C., Hutchings, M., Juul Mylam, K., Brown, P. D. N., Bukh, A.
, Kamper, P., Johnsen, H. E.
& D'Amore, F. A. (2012).
Clinical Features and Outcome in Newly Diagnosed Hodgkin Lymphoma Patients Presenting with PET/CT-Ascertained Focal Skeletal Lesions.
Honoré, B., Andersen, M. D., Wilken, D.
, Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022).
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
Cancers,
14(1), Article 247.
https://doi.org/10.3390/cancers14010247
Hansen, J. J.
, Beier Ommen, H., Gormsen, L. C., d'Amore, F. A. & Hjørnet Kamper, P. M. (2018).
Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.
Case Reports in Hematology,
2018, Article 3726593.
https://doi.org/10.1155/2018/3726593
Leivonen, S. K., Friman, T., Autio, M., Vaittinen, S., Jensen, A. W.
, d’Amore, F., Hamilton-Dutoit, S. J., Holte, H., Beiske, K., Kovanen, P. E., Räty, R. & Leppä, S. (2023).
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Haematologica,
108(11), 3044-3057.
https://doi.org/10.3324/haematol.2023.282831
O'Connor, O. A., Bhagat, G., Ganapathi, K.
, Pedersen, M. B., D'Amore, F., Radeski, D. & Bates, S. E. (2014).
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
Clinical Cancer Research,
20(20), 5240-54. Article e006363.
https://doi.org/10.1158/1078-0432.CCR-14-2020
Gisselbrecht, C., Borchmann, P.
, D'Amore, F., Illidge, T. M. & Zinzani, P. L. (2014).
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
Leukemia Research,
38(9), 1003.
https://doi.org/10.1016/j.leukres.2014.08.013
Hybel, T. E., Vase, M. Ø.
, Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G.
, Hamilton-Dutoit, S., Obel, N.
, Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia and Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741
Vase, M. Ø., Friis, S., Bautz, A., Bendix, K.
, Sørensen, H. T. & d'Amore, F. (2013).
Breast implants and anaplastic large cell lymphoma: A Danish population-based cohort study.
Cancer Epidemiology, Biomarkers & Prevention,
22(11), 2126-2129.
https://doi.org/10.1158/1055-9965.EPI-13-0633
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T.
, Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020).
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Blood,
136(24), 2754-2763.
https://doi.org/10.1182/blood.2020007247
Snipsøyr, M. G.
, Ludvigsen, M., Petersen, E.
, Wiggers, H. & Honoré, B. (2016).
A systematic review of biomarkers in the diagnosis of infective endocarditis.
International Journal of Cardiology,
202, 564-570.
https://doi.org/10.1016/j.ijcard.2015.09.028
Ludvigsen, L. U. P., Andersen, A. S.
, Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P.
, Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023).
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
Journal of Clinical Virology,
167, 105579. Article 105579.
https://doi.org/10.1016/j.jcv.2023.105579
Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D.-Y., Kim, J. S., Jeong, S. H., Yang, D.-H., Jo, J.-C., Lee, G.-W., Choi, C. W., Lee, W.-S., Chen, T.-Y. ... Kim, W. S. (2016).
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Lancet Oncology,
17(3), 389-400.
https://doi.org/10.1016/S1470-2045(15)00533-1
Zinzani, P., Coiffier, B., Radford, J., Caballero, D., Fields, P., Chamuleau, M.
, D'Amore, F. A., Haioun, C., Thieblemont, C., Barca, E., Garcia, C., Johnson, PW., Van Imhoff, G., Saunders, A., Dwyer, K. & Morschhauser, F. (2014).
A phase II open-label, multi-center study of anti-CCR4 monoclonal antibody mogamulizumab (KW-0761) in patients with previously treated peripheral t-cell lymphoma (PTCL).
Blood,
124(21).
Gang, AO., Pedersen, M.
, D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO.
Blood,
120(21).
Pedersen, M.
, D'Amore, F. A., Pedersen, L. M., Jensen, B. A., Jensen, P., Pedersen, B. B., Møller, M. B., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, T. W. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, United States.
de Chadarevian, JP., Wolk, JH., Inniss, S., Lischner, HW.
, d'Amore, F. A., Faerber, EN. & Isaacson, GC. (1997).
A newly recognized cause of wheezing:AIDS-related bronchial leiomyomas. Pediatric Pulmonology,
24((2)), 106-10.
Jepsen, J. R.
, d'Amore, F., Baandrup, U., Clausen, M. R., Gottschalck, E. & Aasted, B. (2009).
Aleutian mink disease virus and humans.
Emerging Infectious Diseases (Print Edition),
15(12), 2040-2.
https://doi.org/10.3201/eid1512.090514
Wulf, G. G., Altmann, B., Ziepert, M.
, D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F. ... ACT-2 study investigators (2021).
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Leukemia,
35(1), 143-155.
https://doi.org/10.1038/s41375-020-0838-5
Bech, M. R., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Deleuran, M. & d'Amore, F. (2013).
Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
British Journal of Dermatology,
169(2), 469-72.
https://doi.org/10.1111/bjd.12324
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP).
British Journal of Dermatology.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (alz) is effective against severe chronic lymphocytic leukemia-associated paraneoplastic pemphigus (pnp).
British Journal of Dermatology,
169(2).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia.
British Journal of Dermatology,
169(2), 469-472.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012).
Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma.
International Journal of Clinical Oncology.
Johnson, P., Federico, M., Kirkwood, A. A., Fossa, A., Berkahn, L., Carella, A.
, d'Amore, F., Enblad, G., Franceschetto, A., Fulham, M. J., Luminari, S., O'Doherty, M. J., Patrick, P., Roberts, T. H., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. N. ... Barrington, S. (2016).
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
The New England Journal of Medicine,
374(25), 2419-2429.
https://doi.org/10.1056/NEJMoa1510093
Sobrero, A., Muzzulini, C.
, d'Amore, F. A., Bogliolo, G., Massa, G., Ghio, R. & Pannacciulli, I. (1982).
Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice.
Cancer Treatment Report,
66(12), 2061-70.
Gang, A. O., Pedersen, M.
, d'Amore, F., Pedersen, L. M., Jensen, B. A., Jensen, P., Møller, M. B., Mourits-Andersen, H. T., Pedersen, R. S., Klausen, T. W. & de N Brown, P. (2015).
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia and Lymphoma,
56(9), 2556-2562.
https://doi.org/10.3109/10428194.2015.1010078